| 
A Houston developer is updating a 64,736-square-foot biomanufacturing and R&D building acquired from Alexandria Real Estate Equities to attract new tenants.
McCord acquired the former GlaxoSmithKline-occupied building at 30 Bearfoot Road in Northborough for $3.35 million and has launched a renovation project to the 1986 building, which features robust primary and standby power, lab waste sanitary system, mechanical mezzanines and 18-foot clear heights.
“The past months have highlighted the importance and complexity of biology,” McCord’s Boston-based partner, Quentin Hart, said in a statement. “At McCord, we understand the importance of creating spaces that can facilitate rapid development and production of discoveries that are vital to the future of biomedical advances.”
JLL’s Dom Domoretsky represents ownership in leasing.
